Results 91 to 100 of about 67,294 (321)

N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes [PDF]

, 2008
Constrictive pericarditis (CP) and restrictive cardiomyopathy share many similarities in both their clinical and hemodynamic characteristics and N-terminal prohormone brain natriuretic peptide (NT-proBNP) is a sensitive marker of cardiac diastolic ...
ARTEAGA, E., BUCK, P.C., FERNANDES, F., IANNI, B.M., MADY, C., NASTARI, L., RAMIRES, F.J.A., SALEMI, V.M.C.   +7 more
core   +2 more sources

Constrictive pericarditis in childhood [PDF]

Archives of Disease in Childhood, 1971
Five children with constrictive pericarditis are described. All underwent surgery to release the restricted heart, and two died. Tuberculosis still plays a major role in the aetiology of this disease; it was proven in one patient and suspected in two others. No other aetiological factors were identified. Clinically, constrictive pericarditis does not
J. F. N. Taylor, A. Simcha
openaire   +3 more sources

Successful Radical Pericardiectomy for Porcelain Constrictive Pericarditis

JACC: Case Reports, 2021
We report the case of a patient with severely calcified constrictive pericarditis and liver cirrhosis who underwent successful off-pump radical pericardiectomy. The cardiac parameters significantly improved without severe complications.
Yusuke Hamada, MD, Koichi Toda, MD, Noriyuki Kashiyama, MD, Shigeru Miyagawa, MD, Yoshiki Sawa, MD   +4 more
doaj  

The Importance of Early Pericardiectomy in Mulibrey Nanism Syndrome, a Case Report

Journal of Investigative Medicine High Impact Case Reports, 2022
Mulibrey ( Mu scle- Liv er- Br ain- Ey e) Nanism syndrome is an extremely rare genetic disorder with multiorgan involvement. Constrictive pericarditis and diastolic dysfunction are the most common causes of mortality.
Andres Cordova Sanchez MC, Mostafa Vasigh MD, Robert Carhart MD   +2 more
doaj   +1 more source

Noninvasive Multimodality Imaging for the Diagnosis of Constrictive Pericarditis: A Contemporary Review

Circulation Cardiovascular Imaging, 2018
There is a need to review the multimodality imaging techniques, as well as the emerging role of the newer noninvasive imaging modalities in the field of constrictive pericarditis (CP).
Wissam Alajaji, Bo Xu, Apichaya Sripariwuth, Vivek Menon, Arnav Kumar, M. Schleicher, H. Isma'eel, P. Cremer, M. Bolen, A. Klein   +9 more
semanticscholar   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Med Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo   +8 more
wiley   +1 more source

Acute Transient Effusive-Constrictive Pericarditis

JACC: Case Reports, 2019
A 52-year-old female developed acute idiopathic pericarditis, which was complicated with tamponade. Constrictive physiology persisted after pericardiocentesis, and effusive-constrictive pericarditis (ECP) was diagnosed.
Kazuhito Hirata, MD, Izumi Nakayama, MD, Minoru Wake, MD   +2 more
doaj  

Radical pericardiectomy for chronic constrictive pericarditis

Journal of cardiac surgery, 2018
We studied the impact of radical pericardiectomy on early and long‐term patient survival, postoperative New York Heart Association (NYHA) functional class, and left ventricular ejection fraction in patients with chronic constrictive pericarditis compared
S. Nozohoor, Mia Johansson, B. Koul, D. Cunha-Goncalves   +3 more
semanticscholar   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Rituximab and pericardiectomy with waffle procedure in constrictive pericarditis due to IgG4‐related disease: A case report

Clinical Case Reports
Key Clinical Message We should consider IgG4‐related disease (IGRD) as one of the potential causes of constrictive pericarditis. In patients with constrictive pericarditis due to IGRD, the combination of surgical treatment and immunosuppressive therapy ...
Toshitaka Okabe, Taishi Kawahata, Yui Koyanagi, Yuki Ito, Yuma Gibo, Takeshi Okura, Naoei Isomura, Akihiro Nabuchi, Hiroshi Okuyama, Masahiko Ochiai   +9 more
doaj   +1 more source